Chart calendar Neurocrine Biosciences, Inc.

a534801a95ce73c.TmD7Qh1hQEyNwcT2s_FS5kchXJDcbsqVi1PKyarq_Rs.CRWBJ28mGXnGpKXEx6MLsA1ZMdaXN7PXwX6HguuZlig4EpobWQ8QD-aRnQ~d4051470194da2eda394325781179ec4

Upcoming events on Neurocrine Biosciences, Inc.

27/05/2026

Annual General Meeting

Day

Past events on Neurocrine Biosciences, Inc.

06/05/2026

Earnings presentation

02:00 am
06/05/2026

Earnings release - Q1 2026

01:30 am
12/02/2026

Earnings presentation

03:00 am
12/02/2026

Earnings release - Q4 2025

02:30 am
16/12/2025

Information meeting

10:30 pm
29/10/2025

Earnings release - Q3 2025

01:30 am
29/10/2025

Earnings presentation

02:00 am
31/07/2025

Earnings presentation

02:00 am
31/07/2025

Earnings release - Q2 2025

01:30 am
21/05/2025

Annual General Meeting

11:00 pm

Annual results

Fiscal PeriodDecember 2023 2024 2025 2026 2027 2028
Net sales
Million USD
Released
Forecast
Spread
1 887
1 885
0.1%
2 355
2 356
-0.04%
2 861
2 843
0.6%

3 762


4 502


5 022

EBITDA
Million USD
Released
Forecast
Spread
269
281
-4.33%
598
626
-4.6%
649
639
1.6%

1 066


1 612


2 012

EBIT
Million USD
Released
Forecast
Spread
251
258
-2.84%
571
617
-7.49%
619
624
-0.84%

508


1 478


1 960

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
332
296
12.11%
486
560
-13.19%
705
688
2.49%

625


1 487


1 932

Net income
Million USD
Released
Forecast
Spread
250
225
11.11%
341
423
-19.31%
479
502
-4.59%

474


1 107


1 418

EPS
USD
Released
Forecast
Spread
2,47
2,22
11.3%
3,29
4,02
-18.19%
4,67
4,96
-5.87%

5,08


10,7


13,3

Announcement Date07/02/2406/02/2511/02/26-

Quarterly results

Fiscal PeriodMarch 2024 Q3 2024 Q4 2025 Q1 2025 Q2 2025 Q3 2025 Q4 2026 Q1 2026 Q2 2026 Q3 2026 Q4 2027 Q1 2027 Q2 2027 Q3 2027 Q4
Net sales
Million USD
Released
Forecast
Spread
622
603
3.21%
628
629
-0.28%
573
561
2.07%
688
654
5.14%
795
747
6.38%
806
789
2.05%
815
765
6.4%

862


1 015


1 047


1 062


1 123


1 167


1 197

EBITDA
Million USD
Released
Forecast
Spread
190
190
0.37%
149
191
-21.77%
31,2
64,8
-51.82%
152
135
12.65%
246
188
30.68%
218
214
1.93%

168


201


315


315













EBIT
Million USD
Released
Forecast
Spread
184
182
0.82%
142
189
-25.03%
23,6
49,6
-52.43%
146
128
13.4%
239
197
21.3%
211
219
-3.83%
193
142
36.67%

188


53,3


307


282


361


408


419

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
190
195
-2.28%
163
206
-21.14%
14,7
73,0
-79.85%
160
135
18.1%
292
205
42.47%
239
229
4.48%
247
156
57.7%

196


35,8


307


282


362


409


420

Net income
Million USD
Released
Forecast
Spread
130
151
-13.99%
103
159
-35.06%
7,90
48,6
-83.74%
108
99,6
7.94%
210
160
31.03%
154
177
-13.33%
198
127
55.47%

165


70,2


227


223


271


300


309

EPS
USD
Released
Forecast
Spread
1,24
1,45
-14.31%
1,00
1,51
-33.87%
0,08
0,50
-83.95%
1,06
0,99
7.54%
2,04
1,59
28.39%
1,48
1,81
-18.17%
1,91
1,18
61.37%

1,59


0,87


2,11


2,59


2,92


3,14


3,25

Announcement Date30/10/2406/02/2505/05/2530/07/2528/10/2511/02/2605/05/26-------
Today

Présentation aux Actionnaires / Analystes

10:30 pm
Today

Annual General Meeting

10:30 pm
15/05/2026

Ex-dividend date - 1.73 USD

09:30 am
15/05/2026

Ex-dividend date - 2.52 USD

09:30 am
15/05/2026

Ex-dividend date - 0.235 USD

09:30 am
15/05/2026

Annual General Meeting

08:30 pm
15/05/2026

Présentation aux Actionnaires / Analystes

09:00 am
15/05/2026

Ex-dividend date - 0.267 CNY

09:30 am
15/05/2026

Earnings release - Annual 2026

12:00 pm
15/05/2026

Earnings presentation

12:30 pm

Past sector events for Neurocrine Biosciences, Inc.

Today

Ex-dividend date - 0.17 GBX

09:30 am
Today

Présentation aux Actionnaires / Analystes

09:00 am
Today

Earnings presentation

01:00 pm
Today

Annual General Meeting

12:00 pm
Today

Significant Split/Dividend

09:30 am
Today

Earnings presentation

06:00 pm
Today

Earnings release - Q4 2026

Today

Board of Directors Meeting

Day
14/05/2026

Earnings release - Q4 2026

Today

Earnings presentation

12:30 pm

Quarterly revenue - Rate of surprise

Net sales - Rate of surprise

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. NBIX Stock
  4. Calendar Neurocrine Biosciences, Inc.